246 related articles for article (PubMed ID: 23394931)
1. Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells.
Yang C; Guo Y; Jadlowiec CC; Li X; Lv W; Model LS; Collins MJ; Kondo Y; Muto A; Shu C; Dardik A
J Surg Res; 2013 Jul; 183(1):478-86. PubMed ID: 23394931
[TBL] [Abstract][Full Text] [Related]
2. Shear stress increases expression of the arterial endothelial marker ephrinB2 in murine ES cells via the VEGF-Notch signaling pathways.
Masumura T; Yamamoto K; Shimizu N; Obi S; Ando J
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2125-31. PubMed ID: 19797707
[TBL] [Abstract][Full Text] [Related]
3. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A
BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311
[TBL] [Abstract][Full Text] [Related]
4. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
Das A; Shergill U; Thakur L; Sinha S; Urrutia R; Mukhopadhyay D; Shah VH
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G908-15. PubMed ID: 20338920
[TBL] [Abstract][Full Text] [Related]
5. Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells.
Iso T; Maeno T; Oike Y; Yamazaki M; Doi H; Arai M; Kurabayashi M
Biochem Biophys Res Commun; 2006 Mar; 341(3):708-14. PubMed ID: 16430858
[TBL] [Abstract][Full Text] [Related]
6. Study of angiogenic signaling pathways in hemangioblastoma.
Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y
Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534
[TBL] [Abstract][Full Text] [Related]
7. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
Groppa E; Brkic S; Uccelli A; Wirth G; Korpisalo-Pirinen P; Filippova M; Dasen B; Sacchi V; Muraro MG; Trani M; Reginato S; Gianni-Barrera R; Ylä-Herttuala S; Banfi A
EMBO Rep; 2018 May; 19(5):. PubMed ID: 29643120
[TBL] [Abstract][Full Text] [Related]
8. Arterial-venous specification during development.
Swift MR; Weinstein BM
Circ Res; 2009 Mar; 104(5):576-88. PubMed ID: 19286613
[TBL] [Abstract][Full Text] [Related]
9. Activation of EphrinB2 Signaling Promotes Adaptive Venous Remodeling in Murine Arteriovenous Fistulae.
Wang T; Liu J; Liu H; Lee SR; Gonzalez L; Gorecka J; Shu C; Dardik A
J Surg Res; 2021 Jun; 262():224-239. PubMed ID: 33039109
[TBL] [Abstract][Full Text] [Related]
10. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
11. EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation.
You C; Zhao K; Dammann P; Keyvani K; Kreitschmann-Andermahr I; Sure U; Zhu Y
J Cell Mol Med; 2017 Sep; 21(9):1848-1858. PubMed ID: 28371279
[TBL] [Abstract][Full Text] [Related]
12. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
[TBL] [Abstract][Full Text] [Related]
13. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
[TBL] [Abstract][Full Text] [Related]
14. Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation.
Zhang G; Zhou J; Fan Q; Zheng Z; Zhang F; Liu X; Hu S
FEBS Lett; 2008 Aug; 582(19):2957-64. PubMed ID: 18671974
[TBL] [Abstract][Full Text] [Related]
15. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis.
Liu ZJ; Shirakawa T; Li Y; Soma A; Oka M; Dotto GP; Fairman RM; Velazquez OC; Herlyn M
Mol Cell Biol; 2003 Jan; 23(1):14-25. PubMed ID: 12482957
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function.
Williams CK; Li JL; Murga M; Harris AL; Tosato G
Blood; 2006 Feb; 107(3):931-9. PubMed ID: 16219802
[TBL] [Abstract][Full Text] [Related]
18. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
[TBL] [Abstract][Full Text] [Related]
19. Molecular identity of arteries, veins, and lymphatics.
Wolf K; Hu H; Isaji T; Dardik A
J Vasc Surg; 2019 Jan; 69(1):253-262. PubMed ID: 30154011
[TBL] [Abstract][Full Text] [Related]
20. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.
Scehnet JS; Ley EJ; Krasnoperov V; Liu R; Manchanda PK; Sjoberg E; Kostecke AP; Gupta S; Kumar SR; Gill PS
Blood; 2009 Jan; 113(1):254-63. PubMed ID: 18836096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
